Oncotyrol is the product of a continuous strategic development of Innsbruck as a top location for cancer research. In 2006/07 the local oncological research community realized that many of their scientific projects had matured and left the realm of basic research. However, they were not advanced enough to be brought to market or sold to industry. At the same time it became clear that cancer medicine was heading more and more towards personalized approaches. This was the birth of Oncotyrol as an incubator structure for applied and personalized cancer research. Oncotyrol fills the gap between basic research and commercial development and it involves the collaboration of clinics, commercial enterprises and academic research groups. Since 2012 it has developed to a business-oriented company that has recently reached the market with first products and services.